4//SEC Filing
Reddy E Premkumar 4
Accession 0001179110-18-006019
CIK 0001130598other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:35 PM ET
Size
7.5 KB
Accession
0001179110-18-006019
Insider Transaction Report
Form 4
Reddy E Premkumar
Director
Transactions
- Purchase
Common Stock
2018-04-27+282,350→ 668,182 total - Purchase
Warrant (right to purchase)
2018-04-27+282,350→ 282,350 totalExercise: $0.42From: 2018-04-27→ Series B Convertible Preferred Stock (7,058.75 underlying)
Footnotes (2)
- [F1]The common stock and warrants reported on this Form 4 were acquired in a public offering, by Onconova Therapeutics, Inc. (the Company), of units which included one share of common stock and one warrant. The public offering price for each unit was $0.425. The public offering, during which the Company also sold other securities, was pursuant to the Company's effective registration statement on Form S-1 (File No. 333-224315).
- [F2]The warrants are exercisable immediately at an exercise price of $0.425 per 0.025 share of Series B Convertible Preferred Stock and will expire on the 18-month anniversary of the date on which the Company publicly announces through the filing of a Current Report on Form 8-K that a Charter Amendment, increasing the number of available common shares, has been filed with the Secretary of State of the State of Delaware.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001580071
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 6:35 PM ET
- Size
- 7.5 KB